FRATES JAMES M
CIK: 0001235598•Chief Financial Officer
OfficerDirector
Primary company: Alkermes plc. (ALKS)
FRATES JAMES M is a corporate insider (Chief Financial Officer) at Alkermes plc. (ALKS) filing SEC Form 4 transactions. 801 transactions across 4 companies, totaling $291,103 in purchases and $44,478,128 in sales. Source: SEC EDGAR.
Companies
Transaction History
Source: SEC EDGAR Form 4 insider transaction filings.
Company | Type | Shares | Price | Value | Shares After | Date | SEC |
|---|---|---|---|---|---|---|---|
| Sale | 10,558 | $14.65 | $155K | 280,430 | 9/30/2025 Filed: 10/2/2025 | Filing → | |
Sage Therapeutics, Inc. SAGE | Disposition | 21,500 | - | - | 0 | 7/31/2025 Filed: 7/31/2025 | Filing → |
Sage Therapeutics, Inc. SAGE | Disposition | 19,154 | - | - | 0 | 7/31/2025 Filed: 7/31/2025 | Filing → |
Sage Therapeutics, Inc. SAGE | U | 2,845 | - | - | 0 | 7/31/2025 Filed: 7/31/2025 | Filing → |
Sage Therapeutics, Inc. SAGE | Award | 21,500 | - | - | 21,500 | 6/11/2025 Filed: 6/13/2025 | Filing → |
| Sale | 10,896 | $3.47 | $38K | 290,988 | 3/31/2025 Filed: 4/2/2025 | Filing → | |
| Award | 102,630 | $3.61 | $370K | 102,630 | 3/6/2025 Filed: 3/10/2025 | Filing → | |
| Award | 68,420 | - | - | 301,884 | 3/6/2025 Filed: 3/10/2025 | Filing → | |
Sage Therapeutics, Inc. SAGE | Award | 19,154 | $6.14 | $118K | 19,154 | 1/3/2025 Filed: 1/6/2025 | Filing → |
| Purchase | 40,000 | $2.53 | $101K | 233,464 | 9/12/2024 Filed: 9/16/2024 | Filing → | |
| Exercise | 18,165 | - | - | 363,835 | 8/23/2023 Filed: 9/5/2024 | Filing → | |
| Exercise | 18,165 | $6.88 | $125K | 73,841 | 8/23/2023 Filed: 9/5/2024 | Filing → | |
Sage Therapeutics, Inc. SAGE | Award | 12,500 | - | - | 12,500 | 6/10/2024 Filed: 6/11/2024 | Filing → |
| Award | 120,000 | - | - | 120,000 | 4/16/2024 Filed: 4/18/2024 | Filing → | |
| Award | 91,180 | - | - | 225,964 | 4/16/2024 Filed: 4/18/2024 | Filing → | |
| Sale | 1,792 | $18.73 | $34K | 134,784 | 3/5/2024 Filed: 3/7/2024 | Filing → | |
| Award | 60,000 | - | - | 60,000 | 2/26/2024 Filed: 2/28/2024 | Filing → | |
| Award | 40,000 | - | - | 152,035 | 2/26/2024 Filed: 2/28/2024 | Filing → | |
| Sale | 2,716 | $16.33 | $44K | 112,035 | 1/9/2024 Filed: 1/11/2024 | Filing → | |
Sage Therapeutics, Inc. SAGE | Award | 4,925 | - | - | 4,925 | 1/3/2024 Filed: 1/4/2024 | Filing → |
Type
Sale
Shares
10,558
Price
$14.65
Value
$155K
Sage Therapeutics, Inc.
SAGE
Type
Disposition
Shares
21,500
Price
-
Value
-
Sage Therapeutics, Inc.
SAGE
Type
Disposition
Shares
19,154
Price
-
Value
-
Sage Therapeutics, Inc.
SAGE
Type
U
Shares
2,845
Price
-
Value
-
Sage Therapeutics, Inc.
SAGE
Type
Award
Shares
21,500
Price
-
Value
-
Type
Sale
Shares
10,896
Price
$3.47
Value
$38K
Type
Award
Shares
102,630
Price
$3.61
Value
$370K
Type
Award
Shares
68,420
Price
-
Value
-
Sage Therapeutics, Inc.
SAGE
Type
Award
Shares
19,154
Price
$6.14
Value
$118K
Type
Purchase
Shares
40,000
Price
$2.53
Value
$101K
Type
Exercise
Shares
18,165
Price
-
Value
-
Type
Exercise
Shares
18,165
Price
$6.88
Value
$125K
Sage Therapeutics, Inc.
SAGE
Type
Award
Shares
12,500
Price
-
Value
-
Type
Award
Shares
120,000
Price
-
Value
-
Type
Award
Shares
91,180
Price
-
Value
-
Type
Sale
Shares
1,792
Price
$18.73
Value
$34K
Type
Award
Shares
60,000
Price
-
Value
-
Type
Award
Shares
40,000
Price
-
Value
-
Type
Sale
Shares
2,716
Price
$16.33
Value
$44K
Sage Therapeutics, Inc.
SAGE
Type
Award
Shares
4,925
Price
-
Value
-
AI Agent
Try asking...